Maille E, Levallet J, Dubois F, Antoine M, et al. A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial. Int J Cancer 2022;150:1889-1904.
PMID: 35262190